Prosecution Insights
Last updated: April 19, 2026
Application No. 18/040,513

HIGH DIMENSIONAL FINGERPRINTS OF SINGLE NANOPARTICLES AND THEIR USE IN MULTIPLEXED DIGITAL ASSAYS

Non-Final OA §102§103
Filed
Feb 03, 2023
Examiner
WECKER, JENNIFER
Art Unit
1797
Tech Center
1700 — Chemical & Materials Engineering
Assignee
UNIVERSITY OF TECHNOLOGY SYDNEY
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
2y 11m
To Grant
99%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allow Rate
490 granted / 692 resolved
+5.8% vs TC avg
Strong +36% interview lift
Without
With
+35.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
27 currently pending
Career history
719
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
48.2%
+8.2% vs TC avg
§102
29.2%
-10.8% vs TC avg
§112
14.1%
-25.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 692 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 24, 26, 29-32 and 47-49 are rejected under 35 U.S.C. 102(a)(1)- as being anticipated by Collins et al (US PGPub 2019/0249081), as cited on the IDS. Regarding Claim 24, Collins et al teaches a method for performing a multiplex assay (see [0008] and [0043]), the multiplex assay including using, as probes, a plurality of upconverting nanoparticles(UCNPs) having luminescence profiles (see [0005], [0040] and [0061]), wherein the luminescence profiles possessing different rising times, peak moments and/or decay times (i.e. different optical properties) (see [0011], [0036] and [0040]) manipulated through an interfacial energy migration (IEM) process, and the probes are distinguished from one another based on their differing rising times, peak moments and/or decay times (see [0037] and [0041]-[0044]). Regarding Claim 26, Collilns et al teaches a method for preparing a library (i.e. a plurality) of spectrally distinct upconverting nanoparticles(UCNPs) (see [0010]-[0011]) comprising: (a) providing a plurality of different classes (sets) of UCNPs, wherein each different class of UCNP nanoparticle has a luminescence profile (i.e. an optical property profile) possessing distinct rising times, peak moments and/or decay times manipulated through a interfacial energy migration (IEM) process (see [0040]-[0044]; and b) varying one or more of the following parameters of the UCNPs of each class so as to provide the library of spectrally distinct UCNPs: core size of the UCNPs (see [0011] and [0041]-[0043]); or concentrations of emitter ions and sensitizer ions in the core (see [0036], [0040]-[0043]). Regarding Claim 29, Collins et al teaches that the different classes (sets) of UCNPs have different combinations of activators (see [0036]) and sensitizers (see [0032], which discloses dopants which act as sensitizers). Regarding Claim 30, Collins et al teaches that the UCNPs comprise one or more of: yttrium and the elements of the lanthanide (Ln) series, i.e., lanthanum (La), cerium (Ce), praseodymium (Pr), neodymium (Ne), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), and lutetium (Lu) (see [0027]). Regarding Claim 31, Collins et al teaches that the UCNPS comprise neodymium, ytterbium, thulium and/or erbium (see [0027]). Regarding Claim 32, Collins et al teaches that the UCNPs contain a host material such as an alkali fluoride selected from the group consisting of NaGdF4, NaYF4 or LiYF4 (see [0029]); an oxide which is Y2O3 (see [0034]) and an oxysulfide (see [0036]). Regarding Claim 40, Collins et al teaches that the plurality of different classes of UCNPs includes the following: core-multi-shell P-NaYF4: Nd3+, Yb3+, Tm3+ UCNPs, core-multi-shell P-NaYF4: Nd3+, Yb3+, Er3+ UCNPs and P-NaYF4: Yb3+, Tm3+ UCNPs (specifically NaYF4 with Yb3+ and Tm3+ ) (see [0061]-[0062] and [0064]). Regarding Claim 47, Collins et al teaches that the UCNPs comprise one or more of: yttrium and the elements of the lanthanide (Ln) series, i.e., lanthanum (La), cerium (Ce), praseodymium (Pr), neodymium (Ne), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), and lutetium (Lu) (see [0027]). Regarding Claim 48, Collins et al teaches that the UCNPS comprise neodymium, ytterbium, thulium and/or erbium (see [0027]). Regarding Claim 49, Collins et al teaches that the UCNPs contain a host material such as an alkali fluoride selected from the group consisting of NaGdF4, NaYF4 or LiYF4 (see [0029]); an oxide which is Y2O3 (see [0034]) and an oxysulfide (see [0036]). Regarding Claim 52, Collins et al teaches that the plurality of different classes of UCNPs includes the following: core-multi-shell P-NaYF4: Nd3+, Yb3+, Tm3+ UCNPs, core-multi-shell P-NaYF4: Nd3+, Yb3+, Er3+ UCNPs and P-NaYF4: Yb3+, Tm3+ UCNPs (specifically NaYF4 with Yb3+ and Tm3+ ) (see [0061]-[0062] and [0064]). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 34, 36, 50 and 51 are rejected under 35 U.S.C. 103 as being unpatentable over Collins et al as applied to claims 24 and 26 above, and further in view of Lannutti et al (US PGPub 2016/0041135). Regarding Claim 34, 36, 50 and 51, Collins et al teaches the method of claim 26, but does not teach that the plurality of different classes of UCNPs includes at least one class having core-multi-shell UCNPs, wherein the core-multi-shell UCNPs comprise a core, a migration layer and a sensitization layer and the migration layer comprises Yb3+, the sensitization layer comprises Yb3+ and Nd3+ or the core comprises Yb3+, Er3+ and/or Tm3+ , Yb3+ and Er3+, or Yb3+ and Tm3+. However, in the analogous art of nanofiber-based sensors, Lannutti et al teaches nanofiber-based sensors which comprise UCNPs such as NaYF.sub.4:Yb,Er and La.sub.2O.sub.3:Yb,Er and La.sub.2(MoO.sub.4).sub.3:Yb,Er (see abstract and [0059]). Furthermore, Lannutti et al teaches that the UCNPs are core-shell nanofibers, wherein the core comprises Yb3+ ,Tm3+ and/or Er3+ (see [0033] and [0059]-[0060]). Lannutti et al does not explicitly disclose that the nanofiber-based sensors include a core, a migration layer and a sensitization layer. However, Lannutti et al teaches the use of multiple intervening nanofiber layers (see [0091]), wherein having multiple shell layers (such as the sensitization and migration layers, having the chemical constituents discussed above), it would have been obvious to modify the core-shell UCNP of Collins et al with the multiple layers described by Lannutti et al in order to provide the benefit of providing the ability to retain identical oxygen levels. Claim(s) 34, 36, 50 and 51 are rejected under 35 U.S.C. 103 as being unpatentable over Collins et al as applied to claims 24 and 26 above, and further in view of Cohen et al (US PGPub 2015/0241349). Regarding Claim 34, 36, 50 and 51, Collins et al teaches the method of claim 26, but does not teach that the plurality of different classes of UCNPs includes at least one class having core-multi-shell UCNPs, wherein the core-multi-shell UCNPs comprise a core, a migration layer and a sensitization layer and the migration layer comprises Yb3+, the sensitization layer comprises Yb3+ and Nd3+ or the core comprises Yb3+, Er3+ and/or Tm3+ , Yb3+ and Er3+, or Yb3+ and Tm3+. However, in the analogous art of synthesis of upconverting nanoparticles (UCNPs), lanthanide-doped hexagonal .beta.-phase sodium yttrium fluoride NaYF.sub.4:Er.sup.3+/Yb.sup.3 nanocrystals, Cohen et al teaches UCNPs which comprise energy transfer upconversion with Yb.sup.3+ as a sensitizer and Er.sup.3+ as an emitter, and thus are able to function at higher power levels (see [0051] and [0073]). Accordingly, it would have been obvious to one of ordinary skill in the art to utilize UCNPs wherein the sensitization layer comprises Yb3+ and Nd3+ or the core comprises Yb3+, Er3+ and/or Tm3+ , Yb3+ and Er3+, or Yb3+ and Tm3+ (as taught by Cohen et al) for the benefit of enabling these UCNPs to be able to function at higher power levels. Claim(s) 41 and 53 are rejected under 35 U.S.C. 103 as being unpatentable over Collins et al as applied to claims 24 and 26 above, and further in view of Bisso et al (US PGPub 2014/0273255). Regarding Claims 41 and 53, Collins et al does not teach that the UCNPs have a coefficient of variation (CV) value less than about 15%, or less than about 10%, or less than about 5%. However, in the analogous art of hydrogel microparticles spatially and spectrally encoded using upconverting phosphor nanoparticles, Bisso et al teaches upconverting phosphor nanoparticles in which mean measured integrated intensity values from fifty microparticles for each type of UCNs were then compared with the expected integrated intensity data obtained from a convolution of the UCN emission data and the image sensor response curves. Table 3 below includes measured mean integrated intensity data, the standard deviation and the coefficient of variability for UCNs in microparticles. Expected integrated intensity data based on emission spectra from UCNs in solution are also included for comparison. As shown in the table, the mean integrated intensity and the expected integrated intensity values are consistent. The average coefficient of variation across all particles and UCN colors was 2% (see [0096]). Accordingly, it would have been obvious to one of ordinary skill in the art that the UCNPs would have a coefficient of variation (CV) value less than 5% (as taught by Bisso et al) for the benefit of providing UCNPs with a low standard deviation and providing decoding error rates of less than 1 ppb. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Zhang et al (US PGPub 20110127445) discloses upconverting phosphor nanoparticles with different emission under the same infrared excitation may be applied to luminescent reporter material for the detection of targeted analytes in multiplexed assays. The Tm.sup.3+ doped yttrium oxysulfide (Y.sub.2O.sub.2S) showed upconversion afterglow emission peak located at 545 nm when it was excited by near infrared light (798 nm). Upconversion emission (red and green) were obtained from the Gd.sub.2O.sub.3:Yb,Er and Gd.sub.2O.sub.2S:Yb,Er particles prepared in the ELM system under the same infrared excitation (.lamda.ex=980 nm) via a two-photon process. Up-conversion phosphor fine particles, about 50 nm in diameter, may be used as a luminescent reporter material for immunoassays or DNA assays (see [0075]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to JENNIFER WECKER whose telephone number is (571)270-1109. The examiner can normally be reached 9:30AM - 6 PM EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Lyle Alexander can be reached at 571-272-1254. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JENNIFER WECKER/ Primary Examiner, Art Unit 1797
Read full office action

Prosecution Timeline

Feb 03, 2023
Application Filed
Dec 01, 2025
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12597493
WORKFLOWS FOR PREPARING AND ANALYZING CLINICAL SAMPLES
2y 5m to grant Granted Apr 07, 2026
Patent 12590962
METHOD FOR PREDICTING FORMATION OF THROMBUS OR RISK OF THROMBUS FORMATION IN MEDICAL DEVICE PERFORMING BLOOD CIRCULATION BY PUMP
2y 5m to grant Granted Mar 31, 2026
Patent 12584035
FLOW CELLS
2y 5m to grant Granted Mar 24, 2026
Patent 12578264
METHOD AND SYSTEM FOR CLASSIFYING MONITORED MOLECULAR INTERACTIONS
2y 5m to grant Granted Mar 17, 2026
Patent 12571802
NANOSWITCH CALIPER TRAINS FOR HIGH-THROUGHPUT, HIGH-RESOLUTION STRUCTURAL ANALYSIS OF BIOMOLECULES
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
99%
With Interview (+35.5%)
2y 11m
Median Time to Grant
Low
PTA Risk
Based on 692 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month